Jim Simons Absci Corp Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$3.41 - $5.74 $1,023 - $1,722	-300 Reduced 0.23%	130,300 $740,000
Q4 2023 Feb 13, 2024	SELL	$1.15 - $4.79 $195,729 - $815,258	-170,200 Reduced 56.58%	130,600 $549,000
Q3 2023 Nov 14, 2023	SELL	$1.28 - $2.41 $156,896 - $295,405	-122,575 Reduced 28.95%	300,800 $397,000
Q2 2023 Aug 11, 2023	BUY	$1.17 - $2.03 $194,775 - $337,944	166,475 Added 64.8%	423,375 $644,000
Q1 2023 May 12, 2023	BUY	$1.58 - $3.41 $308,088 - $664,926	194,993 Added 314.98%	256,900 $450,000
Q4 2022 Feb 13, 2023	BUY	$2.0 - $3.58 $123,814 - $221,627	61,907 New	61,907 $130,000
Q2 2022 Aug 12, 2022	BUY	$3.13 - $8.83 $356,507 - $1.01 Million	113,900 New	113,900 $378,000

128

59.3M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $292M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.